Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nabi completes enrollment for anti-smoking drug trials
The study, designed to evaluate NicVAX’s safety, antibody response to nicotine, and efficacy, will monitor the effects of 100, 200, 300, and 400mcg injections, over a six-month period.
The study, designed to evaluate NicVAX’s safety, antibody response to nicotine, and efficacy, will monitor the effects of 100, 200, 300, and 400mcg injections, over a six-month period.
Betaferon is already an approved and widely used treatment for relapsing-remitting multiple sclerosis (RRMS) in a 250mcg dose. However, the study now seeks to ascertain whether patients could
SPI-339 is an orally available small molecule drug that has potential applications for the treatment of attention disorders, memory acquisition and other cognitive functions. The company hopes that
The company had previously stated that it had reduced its supply expectations for Begrivac in non-US markets from 12 million doses to just four million. However, it now
In most cases, hemophilia is caused by a lack of factor VIII, one of several proteins that enable blood to solidify, or clot, to plug wounds after injury.
With Evotec’s state-of-the-art integrated autopurification and analytical platforms each compound will be of the highest purity to deliver high quality results in Almirall’s pharmaceutical screening and medicinal chemistry
The fast track designation has been awarded to the drug as it is intended for the treatment of a serious or life-threatening condition, and demonstrates the potential to
The RxWise tool, which can be accessed via the web or USB Flash Drive, is designed to evaluate the potential risks for an adverse drug reaction (ADR) by
NBS-101 is being studied as an improved formulation of strontium, which was recently approved in Europe, in the form of strontium ranelate, and launched in several European countries.
The deal will help Aptuit to provide its customers in the biotechnology and pharmaceutical sectors with a suite of early development services and competencies designed to accelerate and